Latest News


Zogenix Viewpoints



03-26-15 Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study
03-10-15 Zogenix Announces Agreement of Sale of Zohydro(R) ER Business to Pernix for $100 Million at Closing Plus Potential Milestones of $283.5 Million
03-10-15 Zogenix Reports Fourth Quarter and Full Year 2014 Financial Results


Latest Entries:

  DosePro is a first-in-class, easy-to-use drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle. DosePro offers benefits to patients including instant, easy dosing, less anxiety over self-injection, no need for sharps disposal, no risk of needle stick injury or contamination, and reliable performance.